Clinical Trials Browser

Fallopian Tube Neoplasms × Sorafenib × Clear all

NCT00436215 2020-11-23

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Phase 2 Completed

55 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00522301 2016-02-29

Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission

Phase 2 Terminated

6 enrolled 5 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms